Different Approaches of Spinal Anesthesia in Patients Undergoing Cesarean Section

December 7, 2022 updated by: Muhammad Ali Fayyaz, Bahawal Victoria Hospital Bahawalpur

Different Approaches of Spinal Anesthesia in Patients Undergoing Cesarean Section: Midline, Paramedian and Taylors Approach

The goal of this clinical trial is to compare different approaches of spinal anesthesia in pregnant females who are having cesarean section. The main aim is

• Which approach is better in terms of avoiding intraoperative and post operative complications

Participants will be given anesthesia by

  1. Midline approach
  2. paramedian approach
  3. Taylors approach

Study Overview

Detailed Description

  1. Introduction to study:

    Different techniques and modalities are used to anesthetize the patient for the smooth conduction of surgery including, general anesthesia, spinal anesthesia, different types of regional anesthesia and monitored anesthesia care.1 According to the authors' knowledge, limited local studies are available that compare midline to the paramedian approach, Taylor's approach and Transforaminal approach of spinal anesthesia in the context of occurrence of post-dural puncture headaches, backache, hematoma, paresthesia, pulse, blood pressure, respiratory rate, temperature and urine output.3

  2. Problem statement:

    Post-dural puncture headache is defined as a bilateral headache that develops within 7 days after dural puncture. It characteristically worsens 15 minutes after resuming sitting position and improves or disappears within 30 minutes of resuming supine position. It can be managed with medical as well as autologous epidural blood patch. It may result in prolonged recovery and delayed mobilization as well as psychosomatic side effects. More sinister side effects like subdural hematoma and seizures are rare but may prove fatal.2 The exact mechanism of development of postdural puncture headache is unclear. The postulated pathogenesis involves cerebrospinal fluid (CSF) leak through the dural puncture site resulting in intracranial hypotension leading to traction on intracranial structures and vasodilatation of cerebral vessels resulting in headache.2

  3. Objectives of this research:

    i) To find out frequency of Post-dural puncture headache (PDPH) in patients with different groups undergoing different approaches of spinal anesthesia.

    ii) Impact of different approaches of spinal anesthesia on complications of spinal anesthesia. Complications are related to either exaggerated physiologic responses or needle/catheter insertion and include:

    • Post-dural-puncture headache (PDPH)
    • Hypotension and bradycardia secondary to sympathetic blockade
    • Hypothermia
    • Respiratory failure resulting from a "high spinal/block"
    • Urinary retention
    • Spinal infection, including aseptic meningitis
    • Spinal or epidural hematoma
    • Nerve or spinal cord damage, possibly resulting in paralysis
    • Pain iii) Impact of different approaches of spinal anesthesia on vitals (pulse, BP, temperature, respiratory rate, spO2 and urine output) intraoperatively and postoperatively.
  4. Limitation of the study:

    The study will be limited to patients undergoing cesarean section. No general population will be involved.

  5. Methodology Paper based questionnaire will be filled out by doctors on duty during pre-operative, operative and post operative period of patients. The study will be a comparative study based on CONSORT randomized control trial in which different groups based on approaches i.e. midline, paramedian, Taylor's and transforaminal approach, will be made. Sampling will involve lottery method. Data will be analyzed by IBM SPSS Statistics Digital Software version 20.0. Data analysis will be done by comparing different groups based on approaches i.e. midline, paramedian, Taylor's and transforaminal approach.

Exclusion Criteria

  1. Patients who refuse to participate in study.
  2. More than 3 attempts of lumber puncture
  3. Previously having migraines of PDPH
  4. Hb less than 7
  5. INR more than 1.2
  6. Previous C-section more than 5
  7. Patients with placenta previa, accrete, percreta and increta
  8. NPO less than 6 hours preoperatively
  9. Patients from gynecological department other than C-section

Study Setting:

Emergency Operation Theatre, Bahawal Victoria Hospital, Bahawlpur.

6. Ethical Consideration Points:

  1. Applied for ERC approval at DME QMC.
  2. Obtained written consent from study participants.
  3. Given autonomy to study participants.
  4. Maintained confidentiality of the data obtained.
  5. Given some beneficial effects to study participants.
  6. No harm to study participants.
  7. Non-maleficence.
  8. Justice and fair play.
  9. No conflict of interest among study authors.
  10. Study funding source mentioned if received from outside, other than study authors.
  11. Appropriate treatment availability at our institution for diseased subjects.
  12. In case of any referral, arrangements for it would be done.
  13. Study results dissemination to study participants would be done.
  14. Plagiarism check report within appreciate limits (less than 20%) is checked by given HEC licensed criteria.
  15. Contribution of each author made in conducting the study is mentioned with his/her name, proper designation and contact number/email.

Study Type

Interventional

Enrollment (Anticipated)

200

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Punjab
      • Bahawalpur, Punjab, Pakistan, 63100
        • Recruiting
        • Bahawal Victoria Hospital Bahawalpur
        • Contact:
        • Sub-Investigator:
          • Fawad Mueen Arbi, MBBS
        • Sub-Investigator:
          • Amit Kumar, MBBS
        • Principal Investigator:
          • Muhammad Ali Fayyaz, MBBS, BSC
      • Bahawalpur, Punjab, Pakistan, 63100
        • Recruiting
        • Bahawalpur Medical & Dental College Bahawalpur
        • Principal Investigator:
          • Muhammad Ali Fayyaz, MBBS, BSC
        • Contact:
      • Lahore, Punjab, Pakistan, 54660
        • Recruiting
        • Hameed Latif Hospital
        • Contact:
        • Sub-Investigator:
          • Mueez Haider, MBBS
      • Multan, Punjab, Pakistan, 61000
        • Recruiting
        • Laeeque Rafiq Hospital (LRH) Multan
        • Contact:
        • Sub-Investigator:
          • Muhammad Anees ur rehman, MBBS, BSC

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 50 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Exclusion Criteria:

  1. Patients who refuse to participate in study.
  2. More than 3 attempts of lumber puncture
  3. Previously having migraines of PDPH
  4. Hb less than 7
  5. INR more than 1.2
  6. Previous C-section more than 5
  7. Patients with placenta previa, accrete, percreta and increta
  8. NPO less than 6 hours preoperatively
  9. Patients from gynecological department other than C-section

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Group M
It will involve participants who are given spinal anesthesia through midline approach.
In the midline approach, the spinal approach to the intrathecal space is midline with a straight line shot. After infiltration with lidocaine, the spinal needle is introduced into the skin, angled slightly cephalic. The needle traverses the skin, followed by subcutaneous fat. A single dose of 12.5mg of 0.5% bupivacaine (preservative free) will be used for the spinal anesthetic, the effects of this will last approximately 2 hours.
Other Names:
  • Bupivacaine
  • Spinal needle
Active Comparator: Group P
It will involve participants who are given spinal anesthesia through paramedian approach.
The paramedian approach involves inserting the spinal needle 1 cm away from the midline in medial direction. A single dose of 12.5mg of 0.5% bupivacaine (preservative free) will be used for the spinal anesthetic, the effects of this will last approximately 2 hours.
Other Names:
  • Bupivacaine
  • Spinal needle
Active Comparator: Group T
It will involve participants who are given spinal anesthesia through Taylors approach.
his arm will have the procedure of spinal anesthetic performed via 'Taylor's approach' which is a paramedian approach to interspace L5 - S1. A single dose of 12.5mg of 0.5% bupivacaine (preservative free) will be used for the spinal anesthetic, the effects of this will last approximately 2 hours.
Other Names:
  • Bupivacaine
  • Spinal needle

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Post-dural-puncture headache (PDPH)
Time Frame: 1 month
PDPH is the most common complication after spinal anesthesia. Our study is based on prevention of PDPH using different approach in spinal anesthesia
1 month

Secondary Outcome Measures

Outcome Measure
Time Frame
Hypotension and bradycardia secondary to sympathetic blockade
Time Frame: 1 day
1 day
Hypothermia
Time Frame: 1 day
1 day
Respiratory failure
Time Frame: 5 days
5 days
Spinal Shock
Time Frame: 1 day
1 day
Urinary retention
Time Frame: 1 month
1 month
Meningitis
Time Frame: 1 month
1 month
Hematoma
Time Frame: 5 days
5 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Muhammad Ali Fayyaz, MBBS, BSC, Bahawal Victoria Hospital Bahawalpur

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 22, 2022

Primary Completion (Anticipated)

December 31, 2022

Study Completion (Anticipated)

January 31, 2023

Study Registration Dates

First Submitted

November 21, 2022

First Submitted That Met QC Criteria

December 1, 2022

First Posted (Actual)

December 5, 2022

Study Record Updates

Last Update Posted (Estimate)

December 9, 2022

Last Update Submitted That Met QC Criteria

December 7, 2022

Last Verified

December 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

IPD Plan Description

This clinical trial is going to be publish in an international journal. To prevent the data from being available to every researcher will not make any difference.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Respiratory Failure

Clinical Trials on Midline Approach

Subscribe